The test that can predict which drugs will benefit individual cancer pat

An Israeli technology developed at the Weizmann Institute makes it possible to determine which drug treatment will be most beneficial for an individual cancer patient and which will not, thus significantly increasing the chances for successful therapy and reducing ineffective treatments and the unnecessary side effects of ineffective treatments. Curesponse’ groundbreaking technology makes it possible […]

Continue Reading